Cargando…

The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers

Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunioka, Shingo, Shirasaka, Tomonori, Miyamoto, Hiroyuki, Shibagaki, Keisuke, Kikuchi, Yuta, Akasaka, Nobuyuki, Kamiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943440/
https://www.ncbi.nlm.nih.gov/pubmed/35371741
http://dx.doi.org/10.7759/cureus.22474
_version_ 1784673517925564416
author Kunioka, Shingo
Shirasaka, Tomonori
Miyamoto, Hiroyuki
Shibagaki, Keisuke
Kikuchi, Yuta
Akasaka, Nobuyuki
Kamiya, Hiroyuki
author_facet Kunioka, Shingo
Shirasaka, Tomonori
Miyamoto, Hiroyuki
Shibagaki, Keisuke
Kikuchi, Yuta
Akasaka, Nobuyuki
Kamiya, Hiroyuki
author_sort Kunioka, Shingo
collection PubMed
description Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especially in high-volume centers. In this study, we investigated the effectiveness of earlier initiation of VA-ECMO for PCS in low-volume centers. Methods We retrospectively assessed patients admitted in two of our related facilities from April 2014 to March 2019. The patients who underwent VA-ECMO during peri- or post-cardiac surgery (within 48 hours) were included. We divided the patients into two groups according to the timing of VA-ECMO initiation. In the early initiation of VA-ECMO group, the “early ECMO group,” VA-ECMO was initiated when patients needed high-dose inotropic support with high-dose catecholamines, such as epinephrine, without waiting for PCS recovery. In the late initiation of VA-ECMO group, the “late ECMO group,” VA-ECMO was delayed until PCS was not controlled with high-dose catecholamines, with the intent of avoiding severe bleeding complications. Results A total of 30 patients were included in the analysis (early ECMO group/late ECMO group: 19/11 patients). Thirty-day mortality in the entire cohort was 60% (n=18), and there was no significant difference between the two groups (early ECMO group/late ECMO group: 64%/55%, p=0.712). Thirteen and six patients died without being weaned off in the early ECMO (43%) and late ECMO groups (55%), respectively; there was no significant difference between the two groups (p=0.696). The median duration of ECMO support was five days (IQR: 1.5-6.5). Conclusions The early initiation of ECMO did not contribute to patients’ 30-day outcomes in low-volume centers. To improve outcomes of ECMO therapy in patients with PCS, centralization of low-volume centers may be required.
format Online
Article
Text
id pubmed-8943440
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89434402022-04-01 The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers Kunioka, Shingo Shirasaka, Tomonori Miyamoto, Hiroyuki Shibagaki, Keisuke Kikuchi, Yuta Akasaka, Nobuyuki Kamiya, Hiroyuki Cureus Cardiac/Thoracic/Vascular Surgery Background and objective Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especially in high-volume centers. In this study, we investigated the effectiveness of earlier initiation of VA-ECMO for PCS in low-volume centers. Methods We retrospectively assessed patients admitted in two of our related facilities from April 2014 to March 2019. The patients who underwent VA-ECMO during peri- or post-cardiac surgery (within 48 hours) were included. We divided the patients into two groups according to the timing of VA-ECMO initiation. In the early initiation of VA-ECMO group, the “early ECMO group,” VA-ECMO was initiated when patients needed high-dose inotropic support with high-dose catecholamines, such as epinephrine, without waiting for PCS recovery. In the late initiation of VA-ECMO group, the “late ECMO group,” VA-ECMO was delayed until PCS was not controlled with high-dose catecholamines, with the intent of avoiding severe bleeding complications. Results A total of 30 patients were included in the analysis (early ECMO group/late ECMO group: 19/11 patients). Thirty-day mortality in the entire cohort was 60% (n=18), and there was no significant difference between the two groups (early ECMO group/late ECMO group: 64%/55%, p=0.712). Thirteen and six patients died without being weaned off in the early ECMO (43%) and late ECMO groups (55%), respectively; there was no significant difference between the two groups (p=0.696). The median duration of ECMO support was five days (IQR: 1.5-6.5). Conclusions The early initiation of ECMO did not contribute to patients’ 30-day outcomes in low-volume centers. To improve outcomes of ECMO therapy in patients with PCS, centralization of low-volume centers may be required. Cureus 2022-02-21 /pmc/articles/PMC8943440/ /pubmed/35371741 http://dx.doi.org/10.7759/cureus.22474 Text en Copyright © 2022, Kunioka et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiac/Thoracic/Vascular Surgery
Kunioka, Shingo
Shirasaka, Tomonori
Miyamoto, Hiroyuki
Shibagaki, Keisuke
Kikuchi, Yuta
Akasaka, Nobuyuki
Kamiya, Hiroyuki
The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers
title The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers
title_full The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers
title_fullStr The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers
title_full_unstemmed The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers
title_short The Early Introduction of Extracorporeal Membrane Oxygenation for Postcardiotomy Cardiogenic Shock Does Not Improve 30-Day Mortality Rates in Low-Volume Centers
title_sort early introduction of extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock does not improve 30-day mortality rates in low-volume centers
topic Cardiac/Thoracic/Vascular Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943440/
https://www.ncbi.nlm.nih.gov/pubmed/35371741
http://dx.doi.org/10.7759/cureus.22474
work_keys_str_mv AT kuniokashingo theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT shirasakatomonori theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT miyamotohiroyuki theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT shibagakikeisuke theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT kikuchiyuta theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT akasakanobuyuki theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT kamiyahiroyuki theearlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT kuniokashingo earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT shirasakatomonori earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT miyamotohiroyuki earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT shibagakikeisuke earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT kikuchiyuta earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT akasakanobuyuki earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters
AT kamiyahiroyuki earlyintroductionofextracorporealmembraneoxygenationforpostcardiotomycardiogenicshockdoesnotimprove30daymortalityratesinlowvolumecenters